Viewing Study NCT00511368


Ignite Creation Date: 2025-12-24 @ 6:26 PM
Ignite Modification Date: 2026-02-11 @ 8:24 AM
Study NCT ID: NCT00511368
Status: COMPLETED
Last Update Posted: 2010-01-20
First Post: 2007-08-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*
Sponsor: Myrexis Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV View
None treatment experienced View
None AIDS View